| Literature DB >> 27380883 |
F K Tabung1,2,3, S E Steck2,3,4, J Zhang2, Y Ma5, A D Liese2,4, F A Tylavsky6, M Z Vitolins7, J K Ockene5, J R Hebert2,3.
Abstract
BACKGROUND/Entities:
Mesh:
Year: 2016 PMID: 27380883 PMCID: PMC5143205 DOI: 10.1038/ejcn.2016.116
Source DB: PubMed Journal: Eur J Clin Nutr ISSN: 0954-3007 Impact factor: 4.016
Figure 1Participant flow in the administration of food frequency questionnaires in the Women's Health Initiative (WHI) Observational Study (OS) and Dietary Modification trial (DM)
Characteristics of study participants, Women's Health Initiative
| Characteristic – N (%) for Categorical Variables | Observational Study (n=76,671) | Dietary Modification Trial intervention arm (n=18,604) | Dietary Modification Trial control arm (n=27,878) |
|---|---|---|---|
|
| |||
| <50-59 | 24144 (31.5) | 6832 (36.7) | 10203 (36.6) |
| 60-69 | 34293 (44.7) | 8681 (46.7) | 13033 (46.7) |
| 70-79 | 18234 (23.8) | 3091 (16.6) | 4642 (16.7) |
|
| |||
| Normal ( <25) | 30577 (39.9) | 5230 (28.1) | 6820 (24.5) |
| Overweight (25.0 - <30) | 26605 (34.7) | 6534 (35.1) | 9940 (35.7) |
| Obese (≥30) | 19489 (25.4) | 6840 (36.8) | 11118 (39.9) |
|
| |||
| Asian or Pacific Islander | 2102 (2.7) | 421 (2.3) | 645 (2.3) |
| African American | 4697 (6.1) | 1932 (10.4) | 2836 (10.2) |
| Hispanic/Latino | 2253 (3.0) | 661 (3.6) | 999 (3.6) |
| European American | 66331 (86.8) | 15263 (82.2) | 22916 (82.3) |
| Other | 1078 (1.4) | 286 (1.5) | 430 (1.6) |
|
| |||
| Some high school or lower educational level | 814 (1.1) | 186 (1.0) | 332 (1.2) |
| High school graduate/some college or associate degree | 21209 (27.9) | 5703 (30.8) | 8609 (31.1) |
| ≥4 years of college | 54067 (71.0) | 12604 (68.2) | 18761 (67.7) |
|
| |||
| Never | 38661 (50.1) | 9502 (51.7) | 14386 (52.1) |
| Former | 32813 (43.3) | 7715 (50.0) | 11370 (41.2) |
| Current | 4242 (5.6) | 1169 (6.3) | 1842 (6.7) |
|
| |||
| Not meeting PA recommendations | 39636 (52.2) | 10860 (65.2) | 16421 (65.7) |
| Meeting PA recommendations | 36254 (47.8) | 5797 (34.8) | 8567 (34.3) |
|
| |||
| No | 36819 (48.0) | 6687 (35.9) | 9732 (34.9) |
| Yes | 39852 (52.0) | 11917 (64.1) | 18146 (65.1) |
| −1.14 (2.58) | −1.32 (2.63) | −0.65 (2.64) | |
NSAIDs=Non-steroidal Anti-inflammatory Drugs
DII components available in the WHI FFQ were: alcohol, beta carotene, caffeine, carbohydrates cholesterol, total energy, total fat, saturated fat, fiber, folic acid, iron, magnesium, niacin, riboflavin, thiamin, zinc, monounsaturated fatty acid(fa) polyunsaturated fa, omega 3 fa, omega 6 fa, trans fat, protein, selenium, vitamins B12, B6, A, C, D, E, onion, green/black tea, isoflavones; while the following components were not available in the WHI FFQ: ginger, turmeric, garlic, oregano, pepper, rosemary, eugenol, saffron, flavan-3-ol, flavones, flavonols, flavonones, anthocyanidins
Figure 2Average dietary inflammatory index (DII) scores across years of follow-up in the Women's Health Initiative Dietary Modification trial, by study arm. The P-value for the difference in DII scores between intervention and control was <0.0001 at each time point. Numbers of participants were as follows: intervention: 17383, 11,895, and 14,399; control: 25749, 17,974, and 22,302; for Year 1, composite Year 3, and composite Year 6 respectively.
Pair-wise comparisons of the DII means across years of follow-up in the Dietary Modification Trial; Women's Health Initiative
| Visit year | Visit year | LS mean estimate (SE) | p-value | Bonferroni-adjusted p-value |
|---|---|---|---|---|
|
| ||||
| 1 | 3 | −0.22 (0.020) | <0.0001 | <0.0001 |
| 1 | 6 | −0.17 (0.020) | <0.0001 | <0.0001 |
| 3 | 6 | 0.049 (0.021) | 0.0208 | 0.12 |
|
| ||||
| 1 | 3 | −0.22 (0.016) | <0.0001 | <0.0001 |
| 1 | 6 | −0.33 (0.016) | <0.0001 | <0.0001 |
| 3 | 6 | −0.11 (0.017) | <0.0001 | <0.0001 |
NB: 1=year 1, 3=composite year 3, 6=composite year 6;
Figure 3Average dietary inflammatory index scores over time by body mass index category and Dietary Modification trial arm in the Women's Health Initiative.
Figure 4Average dietary inflammatory index (DII) over time by educational level and Dietary Modification trial arm in the Women's Health Initiative.
Figure 5Average dietary inflammatory index (DII) over time by race/ethnicity and Dietary Modification trial arm in the Women's Health Initiative. A/PI=Asian/Pacific Islander, AA=African American, HP=Hispanic, EA=European American
Multivariable predictive model of change in dietary inflammatory index over time in the Observational Study; Women's Health Initiative
| Predictors | β (SE) | P-value (β) |
|---|---|---|
| Baseline DII | −0.44 (0.00) | <0.0001 |
| Body mass index (kg/m2) | ||
| Normal weight (>25) | referent | |
| Overweight(25 - <30) | 0.25 (0.02) | <0.0001 |
| Obese(>30) | 0.10 (0.02) | <0.0001 |
| Race/ethnicity | ||
| European American | referent | |
| African American | 0.48 (0.03) | <0.0001 |
| Asian or Pacific Islander | −0.17 (0.05) | <0.0001 |
| Hispanic | 0.68 (0.05) | <0.0001 |
| Other | 0.07 (0.06) | 0.28 |
| Educational level | ||
| ≥4 years of college | referent | |
| High school graduate/some college or associate degree | 0.31 (0.02) | <0.0001 |
| Some high school or lower educational level | 0.47 (0.10) | <0.0001 |
| Use of NSAIDs | ||
| Yes | referent | |
| No | 0.08 (0.01) | <0.0001 |
| Age group (years) | ||
| 50-59 | referent | |
| 60-69 | −0.04 (0.01) | <0.0001 |
| 70-79 | 0.02 (0.01) | 0.18 |
| Physical activity (minutes/week) | ||
| Meeting PA recommendation | referent | |
| Not meeting PA recommendation | 0.26 (0.02) | <0.0001 |
| Smoking status | ||
| Never | referent | |
| Former | −0.07 (0.02) | <0.0001 |
| Current | 0.24 (0.03) | <0.0001 |
| Hypertension status | ||
| No | referent | |
| Yes | 0.06 (0.01) | <0.0001 |
| Diabetes | ||
| No | referent | |
| Yes | 0.10 (0.02) | <0.0001 |
| Use of estrogen & progesterone | ||
| None | referent | |
| < 5y | 0.00 (0.02) | 0.91 |
| 5 to <10y | −0.10 (0.02) | 0.0001 |
| 10 to <15y | −0.09 (0.02) | 0.0002 |
| ≥15y | 0.10 (0.04) | 0.02 |
NB: Starting model for prediction include: baseline DII, education, BMI, race/ethnicity, study year, age, physical activity, smoking status, use of NSAIDs, statins, anti-depressants, history of hypertension, diabetes, cancer, use of estrogen, combined of use of estrogen and progesterone. The final model included: baseline DII, education, BMI, race/ethnicity, age, physical activity, smoking status, diabetes, and combined of use of estrogen and progesterone.